Community Forums |
---|
Real World Evidence RWD for Regulatory Decision-Making: Learnings from Use Cases and Demonstration Projects FDA guidance is clear that real-world data (RWD) may be acceptable for regulatory approval when a randomised controlled trial is not feasible and the validity and trustworthiness of the real-world study results are clearly demonstrated. To provide more operationalised guidance for meeting these standards, the presenters will share learnings from FDA use cases and ongoing demonstration projects. Emerging Trends & Innovation Responsible AI in a Healthcare System As artificial intelligence (AI) moves from being a curiosity to a necessity, it is clear that the benefit obtained from using AI models to prioritise care interventions is an interplay of the models’ performance, the capacity to intervene, and the benefit/harm profile of the interventions. After a brief review of the use cases that AI can serve across medical specialties, we will discuss Stanford Health Care’s efforts to shape the adoption of health AI tools to be useful, reliable and fair so they lead to cost-effective solutions that meet healthcare’s needs. |
Webinars |
---|
Risk Based Quality Management Make the Most Out of Innovation and Ensure it’s Done Right! Join the webinar to learn why change is not only an idea but a necessity. We will explore where old habits need to be retired and where new initiatives have proven to increase efficiency and reduce cost without impacting on quality. This webinar took place virtually on 20 February 2025. |